Digitalization and Technological Advancements in the US Healthcare Advertising Market - Growth, Opportunity and Forecasts 2021-2026 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "US Healthcare Advertising Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

The US healthcare advertising market exhibited moderate growth during 2015-2020. Healthcare advertising is increasingly becoming important in the United States to create awareness about various diseases and health issues along with the drugs and procedures required for treatments. Unlike advertising in other industries, healthcare advertising is very different and has multiple layers of regulations. Advertising in the healthcare sector is subjected to regulations not just by the Federal Trade Commission and state consumer protection agencies but also by a host of other regulatory bodies.

In the United States, healthcare corporations are increasing their expenditure on advertising through various channels like, television, print ads, social media, detailing, etc. and there is a shift of healthcare brands putting more money into the digital space. Digital advertising is slowly but steadily becoming an integral part of the healthcare and pharmaceutical advertising in the US. There is an increased spending on digital channels like social networking websites, online advertisements, mobile web, etc. as consumers and healthcare providers spend most of their time online and on mobile devices.

The U.S. healthcare system is also in the midst of this digital transformation with the introduction of electronic health records, telemedicine and remote medical monitoring. Some of the other factors that are driving the US healthcare advertising market include new drug launches, technological advancements, healthcare reforms, ageing population and an increasing presence of generic and me-too drugs. Looking forward, the publisher expects the US healthcare advertising market to reach a value of US$ 24.7 Billion by 2026, exhibiting a CAGR of 6.10% during 2021-2026.

The key healthcare segments analysed in this report are the Pharmaceuticals (small molecule drugs) Market, Biopharmaceuticals Market, Vaccines Market and Over-the-Counter (OTC) Drugs Market in the United States. For each of the healthcare segments, the report provides the share of various advertising channels such as detailing, sampling, Direct-to-Consumer (DTC), mailing/e-mailing, print advertising, etc. The report finds that detailing represents the most preferred mode of promotion across all the healthcare segments.

The healthcare market in the United States comprises of major players like Johnson & Johnson, Pfizer, Merck & Co., GlaxoSmithKline and Roche, among many others. All these pharmaceutical corporations spend a large amount of their earnings on promotions and advertising of their drugs and healthcare products.

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 An Overview of Healthcare Advertising in the United States

5 What Drives the Healthcare Advertising Market in the US?

5.1 Digitalization and other Technological Advancements

5.2 Increasing Presence of Generic and Me-too Drugs

5.3 Government Regulations Supporting DTC Advertising

5.4 Launch of New Drugs

5.5 Increased Consumer Reach through Mobile Advertising

5.6 Other Key Drivers

6 Healthcare Advertising Market: Value Chain

6.1 DTC Advertising

6.2 Detailing

7 Current Trends in Healthcare Advertising

7.1 Focus on Content

7.2 Rise of Multichannel Marketing

7.3 Targeting Consumers with Local Advertising

7.4 Reliance on Social Media

7.5 Surging Mobile Marketing

7.6 Consumers Becoming Researchers

7.7 Information Dispensed through Videos

7.8 Increasing Importance of Online Reviews

8 US Healthcare Advertising Market: SWOT Analysis

8.1 Overview

8.2 Strengths

8.3 Weaknesses

8.4 Opportunities

8.5 Threats

9 US Healthcare Advertising Market: Porter's Five Forces Analysis

9.1 Overview

9.2 Bargaining Power of Buyers

9.3 Bargaining Power of Suppliers

9.4 Degree of Rivalry

9.5 Threat of New Entrants

9.6 Threat of Substitutes

10 US Healthcare Advertising Market

10.1 Historical and Current Market Trends

10.2 Impact of COVID-19

10.3 Market Breakup by Product Type

11 Major Players: Sales and Advertising Spend

• Johnson & Johnson
• Pfizer
• Merck & Co.
• GlaxoSmithKline
• Eli Lilly
• Novartis
• Sanofi
• AstraZeneca
• Bayer Healthcare
• Bristol- Myers Squibb
• Roche

12 Market Challenges

12.1 Trust Gap between Consumers and Advertisers

12.2 Strict Rules and Regulations by FDA

12.3 Unethical Practices

12.4 Macroeconomic Scenario

12.5 Other Challenges

For more information about this report visit https://www.researchandmarkets.com/r/qj6vxa

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.